Thomasw Rademacher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Here, Thomas Rademacher of Emergex Vaccines explains how delivery of virus-specific major MHC class I epitopes to the skin-resident immune system can translate to the presence of antigen-specific memory T-cells at distal sites.

Nat microbiolThomasw rademacherThomas rademacherOxford glycosciencesFounder of the oxford glycobiology instituteMidatech ltdProfessor thomas rademacherEmeritus professorMolecular medicineEmergex vaccinesSevere acute respiratory syndromeUniversity college london medical schoolProfessor rademacherOxford glycobiology instituteVan oers